Get the Stockscreener App
7.62
2.83%
0.21
After Hours:
7.66
0.04
+0.52%
Meiragtx Holdings Plc stock is traded at $7.62, with a volume of 420.71K.
It is up +2.83% in the last 24 hours and down -2.81% over the past month.
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
See More
Previous Close:
$7.41
Open:
$7.6
24h Volume:
420.71K
Relative Volume:
1.09
Market Cap:
$613.34M
Revenue:
$27.42M
Net Income/Loss:
$-168.69M
P/E Ratio:
-3.6047
EPS:
-2.1139
Net Cash Flow:
$-121.04M
1W Performance:
+2.56%
1M Performance:
-2.81%
6M Performance:
-6.96%
1Y Performance:
-2.18%
1-Day Range:
$7.51
$7.76
1-Week Range:
$7.1485
$7.76
52-Week Range:
$4.55
$9.73
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Name
Meiragtx Holdings Plc
Sector
Industry
Phone
646-860-7985
Address
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
7.62 | 596.44M | 27.42M | -168.69M | -121.04M | -2.1139 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Initiated | H.C. Wainwright | Buy |
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jul-31-24 | Resumed | Chardan Capital Markets | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Sep-15-20 | Resumed | BofA Securities | Buy |
| Sep-03-19 | Initiated | Piper Jaffray | Overweight |
| Feb-27-19 | Reiterated | Chardan Capital Markets | Buy |
| Jul-03-18 | Initiated | Barclays | Overweight |
| Jul-03-18 | Initiated | BofA/Merrill | Buy |
View All
Meiragtx Holdings Plc Stock (MGTX) Latest News
MeiraGTx (NASDAQ:MGTX) CEO Sells $459,420.00 in Stock - MarketBeat
MeiraGTx Holdings plc (MGTX) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Meiragtx Holdings Insider Sold Shares Worth $459,420, According to a Recent SEC Filing - marketscreener.com
Insider Sell Alert: Alexandria Forbes Sells 62,000 Shares of Mei - GuruFocus
Forbes Alexandria, president & CEO of MeiraGTx, sells $459k in MGTX stock By Investing.com - Investing.com South Africa
Forbes Alexandria, president & CEO of MeiraGTx, sells $459k in MGTX stock - Investing.com
MeiraGTx (MGTX) CEO sells 62K shares at $7.41 under 10b5-1 plan - Stock Titan
How (MGTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Earnings Report: Is MeiraGTx Holdings plc gaining market shareForecast Cut & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Should I invest in MeiraGTx Holdings plc before earningsMarket Sentiment Review & Low Risk High Win Rate Picks - baoquankhu1.vn
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
MGTX PE Ratio & Valuation, Is MGTX Overvalued - Intellectia AI
MeiraGTx Holdings PLC $MGTX Shares Sold by Prosight Management LP - MarketBeat
MeiraGTx Holdings Stock (ISIN: US58550P1012) Faces Earnings Spotlight Amid Volatility and Analyst Op - AD HOC NEWS
Trading Systems Reacting to (MGTX) Volatility - Stock Traders Daily
MeiraGTx (NASDAQ:MGTX) Upgraded by Zacks Research to Hold Rating - MarketBeat
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading VolumeTime to Buy? - MarketBeat
MeiraGTx Holdings PLC expected to post a loss of 57 cents a shareEarnings Preview - TradingView
MeiraGTx (NASDAQ:MGTX) Stock Price Down 9.6%Here's What Happened - MarketBeat
MeiraGTx (MGTX) to Release Quarterly Earnings on Thursday - Defense World
MGTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How Meiragtx Holdings Plc (MGTX) Affects Rotational Strategy Timing - Stock Traders Daily
MeiraGTx stock rises on exclusive licensing deal with ZipBio for eye disease therapy - Investing.com Nigeria
Revenue per share of MeiraGTx Holdings Plc – FWB:328 - TradingView
Aug Weekly: Does MeiraGTx Holdings plc have consistent dividend growthAnalyst Downgrade & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
MeiraGTx Holdings Plc (MGTX): Investor Outlook With A Potential 249% Upside - DirectorsTalk Interviews
MGTX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is MeiraGTx Holdings plc gaining market share2025 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
MeiraGTx (MGTX) CFO reports RSU vesting and tax-share withholding - Stock Titan
MeiraGTx (MGTX) CEO vests 62,500 RSUs, withholds shares for taxes - Stock Titan
MeiraGTx (MGTX) CMO reports RSU vesting and tax-share withholding on Form 4 - Stock Titan
MeiraGTx Holdings plc (MGTX) Stock Analysis: Unveiling a 254.77% Potential Upside in Gene Therapy Innovations - DirectorsTalk Interviews
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
(MGTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors - MSN
MGTX Should I Buy - Intellectia AI
MeiraGTx (NASDAQ:MGTX) Trading Up 1.7%Should You Buy? - MarketBeat
Is MeiraGTx Holdings plc’s ROIC above industry averageJuly 2025 Levels & Safe Swing Trade Setups - mfd.ru
Resistance Check: Is MeiraGTx Holdings plc stock a good dividend stockPortfolio Performance Summary & Fast Gain Swing Trade Alerts - mfd.ru
Why MeiraGTx Holdings plc stock attracts high net worth investorsWeekly Stock Summary & Weekly Watchlist for Consistent Profits - mfd.ru
MeiraGTx Holdings Plc (MGTX): Investor Outlook With A Potential 263% Upside - DirectorsTalk Interviews
What is MeiraGTx Holdings plc s debt to equity ratioTrade Performance Summary & High Conviction Buy Zone Picks - mfd.ru
Risk Check: Should I invest in MeiraGTx Holdings plc before earningsTrade Exit Report & Short-Term Swing Trade Alerts - baoquankhu1.vn
Responsive Playbooks and the MGTX Inflection - Stock Traders Daily
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio - Ophthalmology Times
Meiragtx licenses Zipbio’s gene therapies for geographic atrophy - bioworld.com
Retail Surge: Can MeiraGTx Holdings plc stock outperform in a bear marketWeekly Trading Summary & Fast Gain Swing Alerts - baoquankhu1.vn
Resistance Check: Is Smith Micro Software Inc. gaining market shareTrade Analysis Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
MeiraGTx licenses ZipBio’s AI-designed therapies for geographic atrophy By Investing.com - Investing.com Australia
ZipBio and MeiraGTx Enter Into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy - 富途牛牛
Meiragtx Holdings Plc Stock (MGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):